TRISTAN ORPIN

CIK 1215631 · EVP Clinical Genomics · last filed 2016-11-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.71M

Companies

1

Total Filings

107

Lifetime Open-Market Net

-$31.29M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ILMN EVP Clinical Genomics 118,259 $175.09 $20.71M -$31.29M 107 2016-11-08

Recent Filings · Page 2 of 11

107 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-05-02 ILMN Mixed -$224.8K EDGAR
2013-03-12 ILMN Tax (F) −1,432 -$77.0K EDGAR
2013-01-31 ILMN Mixed +4,833 -$25.3K EDGAR
2013-01-29 ILMN Tax (F) −2,022 -$104.4K EDGAR
2012-03-12 ILMN Grant (A) +10,250 $0 EDGAR
2012-01-31 ILMN Tax (F) −3,084 -$157.9K EDGAR
2011-07-28 ILMN Mixed -$772.4K EDGAR
2011-07-14 ILMN Mixed -$800.5K EDGAR
2011-06-30 ILMN Mixed -$810.3K EDGAR
2011-06-16 ILMN Mixed -$769.0K EDGAR
Showing 1120 of 107
Page 2 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.